Insulin: A critical autoantigen and potential therapeutic agent in type 1 diabetes

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Insulin is a polypeptide hormone secreted by pancreatic β-cells and is critical for glucose homeostasis. Abnormalities in insulin secretion result in various forms of diabetes. Type 1A diabetes is an autoimmune form in which insulin has been identified as a critical autoantigen. Recent studies have identified genetic determinants of insulin-specific autoimmune responses and insulin epitopes targeted by autoreactive T lymphocytes. The study of insulin as an autoantigen has also led to discoveries about basic mechanisms of immunological tolerance and autoimmunity. Experimental and clinical evidence suggests that insulin and insulin-derived peptides may delay and perhaps prevent the development of diabetes. Further clinical trials may identify effective treatment modalities for inhibiting diabetogenic autoimmunity and preventing disease development.

Original languageEnglish (US)
Pages (from-to)419-431
Number of pages13
JournalExpert Review of Clinical Immunology
Issue number3
StatePublished - May 1 2006

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Insulin: A critical autoantigen and potential therapeutic agent in type 1 diabetes'. Together they form a unique fingerprint.

Cite this